Year |
Citation |
Score |
2021 |
Baffi TR, Lordén G, Wozniak JM, Feichtner A, Yeung W, Kornev AP, King CC, Del Rio JC, Limaye AJ, Bogomolovas J, Gould CM, Chen J, Kennedy EJ, Kannan N, Gonzalez DJ, et al. mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif. Science Signaling. 14. PMID 33850054 DOI: 10.1126/scisignal.abe4509 |
0.649 |
|
2011 |
Gould CM, Antal CE, Reyes G, Kunkel MT, Adams RA, Ziyar A, Riveros T, Newton AC. Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form Journal of Biological Chemistry. 286: 28922-28930. PMID 21715334 DOI: 10.1074/Jbc.M111.272526 |
0.665 |
|
2010 |
Hoshi N, Langeberg LK, Gould CM, Newton AC, Scott JD. Interaction with AKAP79 modifies the cellular pharmacology of PKC. Molecular Cell. 37: 541-50. PMID 20188672 DOI: 10.1016/J.Molcel.2010.01.014 |
0.711 |
|
2009 |
Gould CM, Kannan N, Taylor SS, Newton AC. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail. The Journal of Biological Chemistry. 284: 4921-35. PMID 19091746 DOI: 10.1074/Jbc.M808436200 |
0.748 |
|
2008 |
Gould CM, Newton AC. The life and death of protein kinase C Current Drug Targets. 9: 614-625. PMID 18691009 DOI: 10.2174/138945008785132411 |
0.693 |
|
2008 |
Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C, Lowry C, Newton AC, Mao Y, Miao RQ, Sessa WC, Qin J, Zhang P, Su B, Jacinto E. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. The Embo Journal. 27: 1932-43. PMID 18566586 DOI: 10.1038/Emboj.2008.120 |
0.756 |
|
2007 |
Chen D, Gould C, Garza R, Gao T, Hampton RY, Newton AC. Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase. The Journal of Biological Chemistry. 282: 33776-87. PMID 17893151 DOI: 10.1074/Jbc.M703320200 |
0.716 |
|
2002 |
Gould C, Wong CF. Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis. Pharmacology & Therapeutics. 93: 169-78. PMID 12191609 DOI: 10.1016/S0163-7258(02)00186-9 |
0.57 |
|
Show low-probability matches. |